GeneOhm Sciences, Inc. Announces Evanston Northwestern Healthcare System MRSA Testing Program; World Class Healthcare Institution Initiates Screening Program
10/19/2005 5:09:12 PM
SAN DIEGO--(BUSINESS WIRE)--Sept. 1, 2005--GeneOhm Sciences, an emerging leader in molecular diagnostics, is pleased to announce that the Evanston Northwestern Healthcare (ENH) system has selected GeneOhm's IDI-MRSA(TM) assay for use in a comprehensive, hospital-wide admission screening program to detect colonization by Methicillin-resistant Staphylococcus aureus (MRSA). This first-of-its-kind program in the U.S. will assess all admissions to the hospital for determination of colonization with MRSA. The IDI-MRSA(TM) assay is currently in use at numerous leading institutions in the US, Canada, UK, and Europe.
Evanston Northwestern Healthcare is a leader in advancing medicine to improve patient care. The group has been screening high-risk patients for the past two years and has selected GeneOhm's rapid molecular-based method for expansion of the testing of admissions. The three-hospital wide program will identify those patients who are colonized with MRSA almost immediately on admission, allowing physicians and staff to provide the best and most immediate treatment opportunities for the patient.
comments powered by